Skip to content

Longitudinal Followup of Patients Under Substitution Therapy From the Moment They Enter a Specialized Care Center for Addicts to the Period They Are Monitored by a General Practitioner Outside the Specialized Care Center

Longitudinal Followup of Patients Under Substitution Therapy From the Moment They Enter a Specialized Care Center for Addicts to the Period They Are Monitored by a General Practitioner Outside the Specialized Care Center

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02245685
Enrollment
113
Registered
2014-09-19
Start date
2008-01-31
Completion date
2014-06-30
Last updated
2017-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction

Keywords

Substitution Therapy, Specialized Care Center for Addicts

Brief summary

This study is part of the french priorities of the 2007-2011 addiction plan. Priority #2 of the plan underlines the need to improve practices and access to opioid substitution treatment. Priority 3 stresses the importance of articulation and coordination between specialized structures and community medicine to optimize the quality of care and to ensure continuity in the followup of these patients. This study focuses on the followup of patients under substitution therapy from the moment they enter a specialized care center for addicts to the period they are monitored by a general practitioner outside the specialized care center. The assessment described in this study should allow to harmonize and keep a continuity in patient monitoring.

Interventions

None listed

Sponsors

French Health Products Safety Agency
CollaboratorOTHER_GOV
Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients entering a specialized medical care center for addicts

Exclusion criteria

* Patients refusing to sign the consent for participation

Design outcomes

Primary

MeasureTime frame
Evolution of the severity score to heroin addiction (TMSP score)From the time patients start to be followed in the specialized care center to the time they leave the specialized care center (up to 5 years)

Secondary

MeasureTime frame
Evolution of the score of quality of life scaleFrom the time patients start to be followed in the specialized care center to the time they leave the specialized care center (up to 5 years)
Evolution of the severity score to heroin addiction (TMSP score)From the time patients leave the specialized care center to the time they are followed by a general practitioner (up to 5 years)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026